2014 Snapshot: How the Golden State Fared in Biotech
California is known as an innovator in the national and global life sciences community, garnering more federal biomedical research dollars than any other state in the country.
As a new year approaches, we’ve teamed up with PricewaterhouseCoopers — to release our latest report looking at the performance of our state’s life sciences ecosystem.
Here’s a look at some of the numbers:
- 767,300. Number of California jobs that are supported by the life sciences industry.
- 2,636. Number of life sciences companies located in California.
- $3 billion. The amount of funding from the National Institutes of Health (NIH) to be awarded to California researchers in federal fiscal year 2014.
- $3.8 billion. Total life sciences venture capital dollars projected to be invested in California companies in 2014.
- 4%.Rate of growth in California’s biopharmaceutical and medical device employment from 2009 to 2013.
- 11. Number of California schools that are ranked in the world’s top 100, according to the Shanghai Index. They are (in alphabetical order): California Institute of Technology; Scripps Research Institute; Stanford University; UC Berkeley; UC Davis; UC Irvine; UC Los Angeles; UC San Diego; UC San Francisco; University of Southern California.
- 1,205. Number of new medicines under development by companies in California.
- 1,228. Total of people in California who earned life sciences doctoral degrees in 2012.
- $101,540. The average salary of a life sciences professional in California.
While the report paints a positive picture for California’s 2014 life sciences sector, it also conveyed a major theme: The state can’t afford to rest on its laurels.
“We must work actively to ensure that California maintains an environment that fosters biomedical research, investment and job creation,” Todd E. Gillenwater, President and CEO of the California Healthcare Institute, said in the report.
Click here to read the 2015 California Biomedical Industry Report.